American Century Companies’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,206
Closed -$577K 2858
2025
Q1
$577K Sell
31,206
-3,693
-11% -$66.6K ﹤0.01% 2457
2024
Q4
$575K Sell
34,899
-20,635
-37% -$292K ﹤0.01% 2455
2024
Q3
$779K Buy
55,534
+8,157
+17% +$90.2K ﹤0.01% 2329
2024
Q2
$343K Buy
47,377
+562
+1% +$3.84K ﹤0.01% 2573
2024
Q1
$378K Buy
46,815
+29,913
+177% +$268K ﹤0.01% 2549
2023
Q4
$115K Buy
+16,902
New +$94K ﹤0.01% 2797
2021
Q4
Sell
-659,950
Closed -$10.4M 2317
2021
Q3
$10.4M Buy
659,950
+133,209
+25% +$2.39M 0.01% 838
2021
Q2
$11.4M Sell
526,741
-11,809
-2% -$239K 0.01% 784
2021
Q1
$10.9M Buy
538,550
+53,477
+11% +$1.06M 0.01% 760
2020
Q4
$8.68M Buy
+485,073
New +$7.12M 0.01% 787

Other funds holding AXGN

American Century Companies's AXGN Position: Q2 2025 in Review

American Century Companies sold out of Axogen (AXGN) in Q2 2025, closing a stake of 31,206 shares — an estimated $577K sold.

American Century Companies first reported a position in AXGN in Q4 2020 and held it in 10 quarters. The position peaked at $11.4M in Q2 2021. 155 funds tracked by Wall St. Rank hold AXGN as of Q2 2025.

  • American Century Companies reported no remaining Axogen position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 31,206 Axogen shares in Q2 2025, an estimated $577K.
  • American Century Companies first reported a position in Axogen in Q4 2020 and held it in 10 quarters.
  • American Century Companies's Axogen position peaked at $11.4M in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Axogen as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.